Figures and Tables
From the following article:
Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers
Mark R. Trusheim, Ernst R. Berndt & Frank L. Douglas
Nature Reviews Drug Discovery 6, 287-293 (April 2007)
doi:10.1038/nrd2251
Figure 1
The patient therapeutic continuum.
Figure 2
Stratified medicine in the clinical context.
Figure 3
Necessary conditions for stratified medicine.
Figure 4
Different types of high-revenue medicines.
Figure 5
Potential effects of stratified medicine on the economic value of therapies.
Table 1
Potential drug development futures
